Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    August 2017
  1. KMIETOWICZ Z
    More patients are surviving heart failure, audit finds.
    BMJ. 2017;358:j3860.
    PubMed     Text format    


    July 2017
  2. MAYOR S
    Decreased risk of sudden death in heart failure questions need for ICDs.
    BMJ. 2017;358:j3309.
    PubMed     Text format    


    May 2017
  3. WISE J
    Routine use of beta blockers in MI patients without heart failure is questioned.
    BMJ. 2017;357:j2635.
    PubMed     Text format    


  4. HAWKES N
    Shortcomings in heart failure drug trial open "can of worms".
    BMJ. 2017;357:j2218.
    PubMed     Text format    


  5. WISE J
    Heart failure is still as "malignant" as some cancers, study finds.
    BMJ. 2017;357:j2179.
    PubMed     Text format    


    April 2017
  6. HAWKES N
    The BMJ Awards 2017: Cardiology.
    BMJ. 2017;357:j1912.
    PubMed     Text format    


  7. MAYOR S
    Patients with chronic heart failure have "extreme" comorbidity, finds primary care study.
    BMJ. 2017;357:j1796.
    PubMed     Text format    


    February 2017
  8. EURICH DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR, et al
    Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up.
    BMJ. 2017;356:j413.
    PubMed     Text format     Abstract available


    January 2017
  9. BANGALORE S, Fakheri R, Wandel S, Toklu B, et al
    Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials.
    BMJ. 2017;356:j4.
    PubMed     Text format     Abstract available


    October 2016

  10. beta blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.
    BMJ. 2016;355:i5602.
    PubMed     Text format    


    June 2016
  11. DUKES JW, Dewland TA, Vittinghoff E, Olgin JE, et al
    Access to alcohol and heart disease among patients in hospital: observational cohort study using differences in alcohol sales laws.
    BMJ. 2016;353:i2714.
    PubMed     Text format     Abstract available


  12. KOTECHA D, Altman DG, Collins PD, Flather MD, et al
    Authors' reply to Cunningham and Messerli and colleagues.
    BMJ. 2016;353:i3141.
    PubMed     Text format    


    May 2016
  13. FIGUEROA JF, Tsugawa Y, Zheng J, Orav EJ, et al
    Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: observational study.
    BMJ. 2016;353:i2214.
    PubMed     Text format     Abstract available


    January 2016
  14. LI L, Li S, Deng K, Liu J, et al
    Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.
    BMJ. 2016;352:i610.
    PubMed     Text format     Abstract available


  15. MCILVENNAN CK, Allen LA
    Palliative care in patients with heart failure.
    BMJ. 2016;353:i1010.
    PubMed     Text format     Abstract available


  16. HOES AW
    beta blockers for heart failure.
    BMJ. 2016;353:i2074.
    PubMed     Text format    


  17. KOTECHA D, Manzano L, Krum H, Rosano G, et al
    Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis.
    BMJ. 2016;353:i1855.
    PubMed     Text format     Abstract available


  18. RUTTEN FH, Clark AL, Hoes AW
    How big a problem is heart failure with a normal ejection fraction?
    BMJ. 2016;353:i1706.
    PubMed     Text format    


  19. WISE J
    NICE approves innovative treatment for moderate to severe heart failure.
    BMJ. 2016;353:i2402.
    PubMed     Text format    


  20. WISE J
    No increased heart failure risk is reported with DPP-4 inhibitors.
    BMJ. 2016;353:i2363.
    PubMed     Text format    


  21. PATEL T, Tesfaldet B, Gandotra C
    Pooled patient level data are better suited than study level data to investigate the link between dipeptidyl peptidase-4 inhibitors and the risk of heart failure in type 2 diabetes.
    BMJ. 2016;353:i2920.
    PubMed     Text format    


  22. EMDIN CA, Wong CX, Hsiao AJ, Altman DG, et al
    Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies.
    BMJ. 2016;532:h7013.
    PubMed     Text format     Abstract available


  23. BOLEN SD, Maruthur NM
    The safety of incretin based drug treatments for type 2 diabetes.
    BMJ. 2016;352:i801.
    PubMed     Text format    


  24. MCCARTHY M
    Commonly used drugs and supplements can worsen heart failure, US doctors warn.
    BMJ. 2016;354:i3886.
    PubMed     Text format    


  25. HIPPISLEY-COX J, Coupland C
    Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.
    BMJ. 2016;354:i3477.
    PubMed     Text format     Abstract available


  26. WISE J
    Simple blood test for heart failure should be more widely available, say MPs.
    BMJ. 2016;354:i4953.
    PubMed     Text format    


  27. PUYMIRAT E, Riant E, Aissoui N, Soria A, et al
    beta blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.
    BMJ. 2016;354:i4801.
    PubMed     Text format     Abstract available


  28. ARFE A, Scotti L, Varas-Lorenzo C, Nicotra F, et al
    Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study.
    BMJ. 2016;354:i4857.
    PubMed     Text format     Abstract available


  29. ADAMSSON ERYD S, Gudbjornsdottir S, Manhem K, Rosengren A, et al
    Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.
    BMJ. 2016;354:i4070.
    PubMed     Text format     Abstract available


  30. ODUTAYO A, Wong CX, Hsiao AJ, Hopewell S, et al
    Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.
    BMJ. 2016;354:i4482.
    PubMed     Text format     Abstract available


    January 2015
  31. DUMBRECK S, Flynn A, Nairn M, Wilson M, et al
    Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines.
    BMJ. 2015;350:h949.
    PubMed     Text format     Abstract available


  32. MARENGONI A, Onder G
    Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity.
    BMJ. 2015;350:h1059.
    PubMed     Text format    


  33. RUTTEN FH, Hoes AW
    Natriuretic peptide tests in suspected acute heart failure.
    BMJ. 2015;350:h1164.
    PubMed     Text format    


  34. CHEN CY, Stevenson LW, Stewart GC, Bhatt DL, et al
    Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
    BMJ. 2015;351:h3529.
    PubMed     Text format     Abstract available


  35. MAYOR S
    Abnormal extra heartbeats may be modifiable risk factor for heart failure, study shows.
    BMJ. 2015;351:h3674.
    PubMed     Text format    


  36. WISE J
    Cognitive behavioural therapy shows promise in heart failure patients with depression.
    BMJ. 2015;351:h5163.
    PubMed     Text format    


  37. FLEETCROFT R, Ford J, Gollop ND, MacKeith P, et al
    Difficulty accessing data from randomised trials of drugs for heart failure: a call for action.
    BMJ. 2015;351:h5002.
    PubMed     Text format    


  38. ZIFF OJ, Lane DA, Samra M, Griffith M, et al
    Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.
    BMJ. 2015;351:h4451.
    PubMed     Text format     Abstract available


  39. SILVER SA, Shah PM, Chertow GM, Harel S, et al
    Risk prediction models for contrast induced nephropathy: systematic review.
    BMJ. 2015;351:h4395.
    PubMed     Text format     Abstract available


  40. COLE GD, Francis DP
    Trials are best, ignore the rest: safety and efficacy of digoxin.
    BMJ. 2015;351:h4662.
    PubMed     Text format    


  41. MAYOR S
    Blood pressure variability is associated with increased risk of heart disease and death, study finds.
    BMJ. 2015;351:h4080.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: